Sangamo Therapeutics, Inc. (SGMO)
Largest Insider Buys in Sector
SGMO Stock Price History Chart
SGMO Stock Performance
About Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops …
Insider Activity of Sangamo Therapeutics, Inc.
Over the last 12 months, insiders at Sangamo Therapeutics, Inc. have bought $0 and sold $0 worth of Sangamo Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Sangamo Therapeutics, Inc. have bought $103,280 and sold $2.17M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 6,784 shares for transaction amount of $25,029 was made by Markels John () on 2022‑06‑03.
List of Insider Buy and Sell Transactions, Sangamo Therapeutics, Inc.
| 2023-09-26 | Sale | 10 percent owner | 6M 2.4552% | $0.50 | $3M | -17.84% | ||
| 2022-08-29 | Sale | 500,000 0.3203% | $5.31 | $2.66M | -46.48% | |||
| 2022-06-03 | 6,784 0.0045% | $3.69 | $25,029 | -5.24% | ||||
| 2022-06-01 | 5,000 0.0034% | $3.60 | $17,996 | -0.28% | ||||
| 2021-12-28 | Sale | 10 percent owner | 2,764 0.002% | $8.51 | $23,522 | -41.00% | ||
| 2021-12-27 | Sale | 10 percent owner | 600 0.0004% | $8.56 | $5,136 | -41.81% | ||
| 2021-12-23 | Sale | 10 percent owner | 81,187 0.0555% | $8.55 | $694,530 | -44.06% | ||
| 2021-12-09 | Sale | 10 percent owner | 23,660 0.0171% | $8.56 | $202,541 | -38.39% | ||
| 2021-12-08 | Sale | 10 percent owner | 75,814 0.0515% | $8.64 | $654,828 | -42.32% | ||
| 2021-12-07 | Sale | 10 percent owner | 52,178 0.036% | $8.52 | $444,437 | -40.32% | ||
| 2021-11-26 | Sale | 10 percent owner | 28,884 0.0202% | $8.60 | $248,434 | -37.99% | ||
| 2021-03-23 | Sale | EVP, General Counsel & Sec. | 17,524 0.0128% | $13.13 | $230,042 | -23.91% | ||
| 2020-12-31 | Sale | EVP, Technical Operations | 2,464 0.0018% | $16.74 | $41,247 | -32.51% | ||
| 2020-12-24 | Sale | EVP, Technical Operations | 3,331 0.0025% | $18.13 | $60,391 | -40.20% | ||
| 2020-12-17 | Sale | director | 10,000 0.0074% | $13.27 | $132,747 | -19.51% | ||
| 2020-03-19 | Sale | director | 35,000 0.0295% | $6.00 | $210,000 | +79.12% | ||
| 2020-03-18 | director | 3,000 0.0024% | $5.20 | $15,585 | +97.48% | |||
| 2020-03-17 | director | 5,000 0.0039% | $4.99 | $24,950 | +99.55% | |||
| 2020-03-16 | Sale | director | 15,000 0.0154% | $6.02 | $90,261 | +116.83% | ||
| 2020-03-13 | director | 5,000 0.0037% | $5.67 | $28,350 | +63.57% |
Insider Historical Profitability
| RA CAPITAL MANAGEMENT, LLC | 1829426 0.8786% | $2.38 | 31 | 48 | <0.0001% | |
| LANPHIER EDWARD O II | President & CEO | 235000 0.1129% | $2.38 | 1 | 42 | +107.09% |
| Wolff Henry Ward | Exec VP & CFO | 197872 0.095% | $2.38 | 1 | 29 | +107.09% |
| PARKER H STEWART | 48700 0.0234% | $2.38 | 4 | 0 | +23.16% | |
| Markels John | 32484 0.0156% | $2.38 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Wasatch Advisors | $13.49M | 9.7 | 20.13M | +62.38% | +$5.18M | 0.07 | |
| Armistice Capital Llc | $11.37M | 8.17 | 16.96M | New | +$11.37M | 0.04 | |
| BlackRock | $8.9M | 6.4 | 13.28M | -5.8% | -$548,376.45 | <0.0001 | |
| The Vanguard Group | $8.18M | 5.88 | 12.2M | -3.17% | -$267,249.60 | <0.0001 | |
| Acadian Asset Management | $3.31M | 2.38 | 4.94M | +4.05% | +$128,859.65 | 0.01 |